Monopar Therapeutics Inc. (MNPR) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Join SI Premium – FREE
Monopar Therapeutics Inc. (NASDAQ: MNPR) reported Q4 EPS of ($0.22), $0.01 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Monopar Therapeutics Inc. (MNPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Citi expects Micron stock to rally into this event
- Capitol Federal Financial names William Skrobacz Jr. as president
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
